CONFORMATIONAL-CHANGES AT MEMBRANES of TARGET-CELLS INDUCED BY PEPTIDE HORMONE ANGIOTENSIN - SPIN LABEL STUDY by Schreier, Shirley et al.
Volume 47, number 1 FEBS LETTERS October 1974 
CONFORMATIONAL CHANGES AT MEMBRANES OF TARGET CELLS INDUCED BY 
THE PEPTIDE HORMONE ANGIOTENSIN. A SPIN LABEL STUDY* 
S. SCHREIER-MUCCILLO, G. X. NICULITCHEFF, M. M. OLIVEIRA, S. SHIMUTA and A. C. M. PAIVA 
Institute of Chemistry, University of SKo Pa&o, Department of Biochemistry, Faculdade de Medici- 
na da Santa Casa, and Department of Biophysics, Escola Paulista de Medicina, SZo Paula, Brazil 
Received 19 August 1974 
1. Introduction 
The mechanism of action of many hormones is 
thought to be based on the interaction between the 
hormone and the membranes of target cells. We have 
examined the interaction of AII** with membranes 
from smooth muscle of guinea pig ileum [l] through 
binding studies with the radioactive hormone and 
monitoring of conformational changes at the 
membranes with the spin label technique [2,3]. 
2. Experimental 
2.1. Materials 
The peptides were prepared by the solid phase 
method [4]. [3H]AII was a gift from Dr P. A. 
Khairallah from the Cleveland Clinic, Ohio, and had a 
specific activity of 40 Ci/mmole. Spin labels were from 
Syva, Palo Alto, Calif. USA. Phospholipids were from 
Lipid Products, South Nutfield, England. 
2.2. Binding experiments 
Aliquots of freshly prepared subcellular fractions 
[ 1 ] (l-2 mg protein) were incubated for 10 min at 
* Supported by grants from FAPESP and CNPq. 
** Abbreviations: AH, angiotensin II; ['HI AH, tritiated AII, 
MSL-6,4-maleimido-2,2,6,6-tetramethyl-piperidinooxyl; 
S-SASL, 2-(3_carboxypropyl)-4,4-dimethyl-2-tridecyl-3- 
oxazolidinyloxyl. 
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37°C with [3H]AII (final concentration 10e8 M) in 
Tyrode solution. GSWP Millipore filters were used to 
separate bound from free AII. Radioactive counting 
of the filters washed with buffer was done with a 
Beckman LS 100 scintillation counter. Correction for 
trapping or adsorption of angiotensin to the fnters in 
the absence of cell fractions was effected. ‘Specific’ 
binding [5] was obtained subtracting the amount that 
was not displaced by native lo-’ M angiotensin II from 
the total radioactive uptake. 
Protein was determined by the method of Lowry 
et al. [6]. Lipids were extracted according to Folch 
et al. [7]. 
2.3. Spin label experiments 
2.3.1. Plasma membranes 
Membranes (0.8-l .5 mg protein/ml) were suspended 
in Tyrode solution, pH 7.5. The incorporation of MSL- 
6 was performed at 4”C, for approx. 12 hr, with 
0.010-0.013 mg label/mg membrane protein. 5SASL, 
at ratios of 0.003-0.0125 mg/mg membrane protein, 
was intercalated by three different procedures (refs. 
[8-IO]). The spectra, taken after 3-4 washings, did 
not depend on the method of probe intercalation. Some 
preparations with higher lipid probe concentration 
displayed some exchange broadened spectra. Samples 
were placed in Pasteur pipettes. 
2.3.2. Model systems 
Lipid dispersions and planar multibilayers were 
prepared as described in ref. [ 1 l] . Flat aqueous cells 
(James Scanlon, Costa Mesa, Calif. USA) were used. 
Spectra were taken with a Varian E-4 esr spectrometer 
at room temperature (22 f 2°C). 
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Fig. 1. Spectra of MSL-6 in plasma membrane from smooth muscle of guinea pig ileum suspended in Tyrode solution. Solid line - 
in the absence of All; dotted line - in the presence of a 1 mM solution of AIL Experimental conditions are given in the text. 
3. Results 
3.1. Binding experiments 
The specific binding of [jH] AI1 to the plasma 
membrane fraction was 160 pmoles/g protein, while 
mitochondria bound only 6.5 pmoles/g protein. No 
binding to microsomes was detected. Therefore, only 
plasma membranes were used for the spin-labelling 
experiments. 
3.2. ESR studies with the protein-specific label 
Membranes containing MSL-6 displayed spectra with 
two components: one characteristic of label bound to 
sites of higher mobility, and another indicative of 
sites where the motion of the label was greatly 
restricted [2] (fig. 1). Addition of a 1 mM solution of 
AI1 produced an increase in the population of label 
in a more hindered environment (fig. 1). 
3.3. ESR studies with the lipid spin probe 
3.3.1. Intact membranes 
Spectra of the stearic acid probe in aqueous 
suspensions of membranes also indicated that it was 
in two different states (fig. 2): one of a high degree of 
mobility, and another where motion was hindered 
(membrane-bound probes). It was difficult to measure 
accurately the separation between the outer extrema 
[ 121 since the spectrum presented a very broad high 
field line (fig. 2). Therefore we did not use changes in 
this parameter to monitor the effect of the hormone. 
The narrow lines have already been observed in other 
membrane preparations [8- IO, 13- 151. They seem 
to be due to probes tumbling more freely in an aqueous 
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Fig. 2. Spectra of S-SASL in plasma membranes from smooth 
muscle of guinea pig ileum suspended in Tyrode solution. a) 
in the absence of AH; b) in the presence of a 1 mM solution of 
AII. Experimental conditions are given in the text. 
environment, as measured by the hyperfine splittings 
and linewidths (ref. [ 161 and our own observations). 
A decrease in their intensity occurred in presence of the 
hormone (fig. 2b). Addition of AI1 (final concentra- 
tion 1 mM) to an aqueous solution of 5-SASL caused 
no spectral changes. The effect of angiotensin was 
concentration dependent (table 1). The effect was 
smaller for 1 mM AI1 when such concentration was 
added to preparations previously treated with 0.01 mM 
hormone, in a way that ressembled the phenomenon 
of tachyphyllaxis, characteristic of the action of AI1 
on the guinea pig ileum [ 171. 
The alterations promoted by two analogs, Leus-AI1 
and Gly’ ,Pro8-AII, occurred to a significantly smaller 
extent (table 1). 
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Table 1 
Effect of angiote~s~n II and analog peptides on the spectra of 5SASL-labelled membranes 
Exp.* (~m/~f)** 
(no peptide 
added) 
- 
0.420 
0.437 
0.228 
0.409 
0.256 
0.344 
0.465 
Peptide added Cont. 
(mM) 
h,/hf** 
(after addn. 
of peptide) 
% change 
AI1 1.00 0.840 100 
AI1 1.00 0.840 92 
All 0.10 0.375 65 
AI1 0.10 0.623 52 
AI1 0.01 0.281 10 
Leu’-A11 1.00 0.448 30 
Gly’ ,Pro’-AI1 1.00 0.598 29 
* The experiments described in this table are representative of a large number of observations. 
** h,/hf is the ratio of the heights of the Low field lines corresponding to membrane-bound (h,) 
and freely tumbling (hf) spin probe. 
3.3.2. Delipidated membranes 
Delipidated membranes retained some of the lipid 
probe, yielding spectra which also presented the narrow 
lines. The relative intensity of the latter also decreased 
upon addition of AU. 
3.3.3. Lipid extracts and model systems 
The spectra yielded by aqueous dispersion of 
membrane lipids underwent no changes when AI1 was 
added. The same was true for films and dispersions of 
known lipid composition. 
4. Discussion 
Our preliminary results with radioactive angiotensin 
show a higher affmity of the hormone for plasma 
membranes than for the other subcellular fractions of 
the intestinal smooth muscle. This binding, observed 
with the hormone concentration needed for half 
maximum contraction in the intact ileum [8], could 
be displaced by native angiotensin. These findings are 
in agreement with previous work with angiotensin 
receptors in rabbit aorta [ 191. This, and results obtained 
with bovine and rat adrenal glands 1201, corroborate 
the current view that certain hormones interact first 
with the plasma membranes of target cells. 
Binding may be a first step, leading to conformational 
changes at the membrane as part of the mechanism of 
hormone action. 
The changes in the spectra of spin labels covalently 
bound to plasma membrane proteins indicate that the 
hormone caused a decreased mobility of a number of 
sites. These results are in line with the finding that the 
hormone caused contraction of the isolated plasma 
membranes [l] . However, the diminished intensity of 
the narrow lines in the spectra of 5SASL upon addition 
of the hormone suggests an enhancement of the fluidity 
of membrane lipid regions, and; as a consequence, an 
increased ‘solubility’ of spin probes in the membrane. 
We ascribe this event to the small lipid: protein ratio 
(1:3), of our membranes. It is conceivable that the 
membrane lipids would tend to expand in order to 
accomodate for protein contraption, but since there 
is a large proportion of protein, the overall result is the 
observed contraction [l] . The fact that delipidated 
membranes gave the same results as intact membranes 
might be explained by the presence of some lipid not 
removed during the delipidation procedure which 
would display the same behaviour as the total lipid. 
Nevertheless, it cannot be ruled out that the relative 
decrease in the intensity of the lines due to more freely 
tumbling 5-SASL might be caused by a tight binding 
of the probe to membrane proteins as a result of the 
interaction with angiotensin. That the site of action 
of the hormone must be protein in nature was shown 
by the absence of an effect in systems containing only 
lipids. 
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Effects that were qualitatively similar to those 
observed with AI1 were also seen both with Leu’-AI1 
(intrinsic activity 48% that of AI1 and pDz * = 5.00, 
as compared with pDz r 8.80 for AI1 [ 171) and with 
Gly’ -Pro’-AI1 (intrinsic activity 96% pDz = 4.00 
[Zl]). However, the effect was consistently and 
significantly more pronounced with AI1 (table 1). This, 
and the tachyphyllactic behaviour, suggest hat a signi- 
ficant part of the membrane conformational changes 
evidenced by the spin label method may be connected 
with the activation of the effector system that follows 
the binding of AI1 to its receptor site. Conformational 
alterations at membranes have been detected with lower 
concentrations of other hormones f22-24 J than in 
our experiments. One possible explanation for the 
high AI] concentrations needed to produce the 
changes reported here may be that a partial loss of the 
effector system occurred during the preparation of the 
membranes. 
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